Immune-Related Polyneuropathy and Generalized Myoclonus Associated with Pembrolizumab in a Patient with Metastatic Melanoma: A Case Report and Literature Review

Pembrolizumab is used to treat metastatic melanoma but may cause neurological immune-related adverse events involving the peripheral and central nervous systems. We report a 45-year-old man who developed painful sensory-motor polyneuropathy and clinically identified negative myoclonus during pembrolizumab-based treatment. Initial cerebrospinal fluid analysis showed lymphocytic pleocytosis and elevated protein, followed by albuminocytologic dissociation on repeat sampling. Electroencephalography (EEG) was unavailable. The initial episode was classified clinically as grade 2 and improved after corticosteroids and symptomatic treatment. Following pembrolizumab reintroduction, severe neurological symptoms recurred in September 2024, with a modified Rankin Scale score of 4, leading to permanent discontinuation. An August 2025 electrophysiological report described persistent severe mixed axonal and demyelinating sensory-motor neuropathy. The patient subsequently developed systemic and brain metastatic progression and died in April 2026. The temporal course supports suspected treatment-related neurological toxicity, but incomplete etiological and electrophysiological characterization limits causal attribution, particularly for myoclonus.

Authors

Institutions

Publication Details

Journal
Brazilian Journal of Case Reports
Published
2026-11-19
DOI
https://doi.org/10.52600/2763-583x.bjcr.2026.6.1.bjcr237
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immune-Related Polyneuropathy and Generalized Myoclonus Associated with Pembrolizumab in a Patient with Metastatic Melanoma: A Case Report and Literature Review

Caio Augusto Pereira, Jorge Alberto Martins Pentiado, Jonatas Crispim Magalhães de Oliveira, Lucas Ravagnani Silva et al.
Brazilian Journal of Case Reports
Cancer Immunotherapy and Biomarkers
article

Immune-Related Polyneuropathy and Generalized Myoclonus Associated with Pembrolizumab in a Patient with Metastatic Melanoma: A Case Report and Literature Review

Caio Augusto Pereira, Jorge Alberto Martins Pentiado, Jonatas Crispim Magalhães de Oliveira, Lucas Ravagnani Silva, Thales Pardini Fagundes, Sérgio Vicente Serrano, Caio Semensato Borges
article en

Abstract

Pembrolizumab is used to treat metastatic melanoma but may cause neurological immune-related adverse events involving the peripheral and central nervous systems. We report a 45-year-old man who developed painful sensory-motor polyneuropathy and clinically identified negative myoclonus during pembrolizumab-based treatment. Initial cerebrospinal fluid analysis showed lymphocytic pleocytosis and elevated protein, followed by albuminocytologic dissociation on repeat sampling. Electroencephalography (EEG) was unavailable. The initial episode was classified clinically as grade 2 and improved after corticosteroids and symptomatic treatment. Following pembrolizumab reintroduction, severe neurological symptoms recurred in September 2024, with a modified Rankin Scale score of 4, leading to permanent discontinuation. An August 2025 electrophysiological report described persistent severe mixed axonal and demyelinating sensory-motor neuropathy. The patient subsequently developed systemic and brain metastatic progression and died in April 2026. The temporal course supports suspected treatment-related neurological toxicity, but incomplete etiological and electrophysiological characterization limits causal attribution, particularly for myoclonus.

Brazilian Journal of Case ReportsVol. 6(1)
Hospital de Câncer de Barretos (BR)
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon